Adverse drug reactions (ADRs) represent a significant challenge to public health, affecting millions of patients worldwide.

Fixed drug eruptions (FDEs) represent a distinctive subset of adverse drug reactions, characterised by the recurrence of lesions at identical anatomical sites with each exposure to the causative ...

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a T-cell–mediated severe cutaneous adverse reaction characterized by rash, fever, internal organ involvement, and systemic ...

Researchers from Queen Mary University of London (QMUL) found that 9% of all adverse drug reactions (ADRs) reported to the Yellow Card database are associated with medications where genetic factors ...

Adverse drug events are more common in older people with comorbidities, a new study finds. Factors that are independently linked with adverse drug events are being female, taking more drugs daily, ...

In the United Kingdom, adverse drug reactions (ADRs) to cardiovascular drugs are very common, especially in older and sicker patients. Prevention may include educating patients, monitoring patient ...

A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect ...

Medicines containing a type of PFAS or 'forever chemical' called fluorine are not leading to higher numbers of adverse drug reactions according to new data analysis. In a new paper published in PLOS ...

Tailoring medicines to an individual’s genetic profile is now possible. One critical aspect is genetic testing that reduces side effects, particularly for patients on psychiatric and cardiovascular ...